TrademarkDir
REJUVENRX
LIVE

Serial Number

90446720

Owner

RejuvenRx Inc.

Attorney

Rachel Jacques

Filing Date

Jan 4, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REJUVENRX Trademark

Serial Number: 90446720 • Registration: 7781520

REJUVENRX is a trademark filed by RejuvenRx Inc. on January 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

RejuvenRx Inc.

2950 chemin Polytechnique
Montreal, Quebec H3T1J4 , CA

Entity Type: 03

Trademark Details

Filing Date

January 4, 2021

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory muscle diseases and disorders, and central nervous system diseases and disorders, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease

Development of pharmaceutical preparations and medicines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 24, 2025 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 18, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 8, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 8, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 8, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 4, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 14, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 14, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 14, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 10, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 16, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 16, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 16, 2024 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 12, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 7, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 7, 2023 GNSL
SUSPENSION LETTER WRITTEN
Aug 7, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 28, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 4, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 4, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
May 4, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 4, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 4, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 4, 2023 CNSL
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 30, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 26, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 26, 2022 GNSL
SUSPENSION LETTER WRITTEN
Aug 26, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2022 CRFA
ASSIGNED TO LIE
Aug 20, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 26, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 11, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 11, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 11, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 27, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 27, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jul 27, 2021 CNSL
ASSIGNED TO EXAMINER
Jul 13, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2021 NWOS
NEW APPLICATION ENTERED
Jan 7, 2021 NWAP

Related Trademarks